2020
DOI: 10.21203/rs.3.rs-34189/v2
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Exploring the experiences of stroke patients treated with transcranial magnetic stimulation for upper limb recovery: a qualitative study

Abstract: Background: Transcranial magnetic stimulation (TMS) treatments have shown promise in improving arm recovery in stroke patients. Currently, little is known about patients’ experiences with TMS treatment, and this lack of knowledge may affect optimal implementation in clinical practice. The aim of this explorative study was to gain insight in the perceived effects and experiences of the design and delivery of a TMS treatment for upper limb recovery from the perspectives of stroke patients. Methods: This qualitat… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…Recently, many studies have investigated the role of direct brain modulation for the treatment and prevention of disease (Johnson et al, 2013; Gauthier et al 2022), though the identity of the perturbed cells remains relatively unknown. For instance, stimulation of brain cells via transmagnetic stimulation (TMS), which is an approved therapy for treatment-resistant MDD, has promising therapeutic value when applied to AD, PD, stroke, schizophrenia, and MS (Weiler et al 2020; Brys et al 2016; van Lieshout et al 2020; Cole et al 2015; Nasios et al 2018). However, understanding how to restore brain patterns through a cell-type specific and targeted manner remains elusive, especially when used for the treatment of brain diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, many studies have investigated the role of direct brain modulation for the treatment and prevention of disease (Johnson et al, 2013; Gauthier et al 2022), though the identity of the perturbed cells remains relatively unknown. For instance, stimulation of brain cells via transmagnetic stimulation (TMS), which is an approved therapy for treatment-resistant MDD, has promising therapeutic value when applied to AD, PD, stroke, schizophrenia, and MS (Weiler et al 2020; Brys et al 2016; van Lieshout et al 2020; Cole et al 2015; Nasios et al 2018). However, understanding how to restore brain patterns through a cell-type specific and targeted manner remains elusive, especially when used for the treatment of brain diseases.…”
Section: Introductionmentioning
confidence: 99%